BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
C10orf2 | Chromosome 10 open reading frame 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
C1S | Complement component 1, s subcomponent | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CA12 | Carbonic anhydrase XII | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CALM1 | Calmodulin 1 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM3 | Calmodulin 3 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CANT1 | Calcium activated nucleotidase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CAPN10 | Calpain 10 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CAPN3 | Calpain 3, (p94) | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CAPN5 | Calpain 5 | Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CASP10 | Caspase 10, apoptosis-related cysteine peptidase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CATSPER2 | Cation channel, sperm associated 2 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CD36 | CD36 molecule (thrombospondin receptor) | Cancer-related genes CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CDK12 | Cyclin-dependent kinase 12 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CDK4 | Cyclin-dependent kinase 4 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CDK9 | Cyclin-dependent kinase 9 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CDKN3 | Cyclin-dependent kinase inhibitor 3 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CEL | Carboxyl ester lipase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CERS3 | Ceramide synthase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
CFB | Complement factor B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CFD | Complement factor D (adipsin) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CFI | Complement factor I | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CHAT | Choline O-acetyltransferase | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
CHD2 | Chromodomain helicase DNA binding protein 2 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CHD5 | Chromodomain helicase DNA binding protein 5 | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
CHD6 | Chromodomain helicase DNA binding protein 6 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CHD7 | Chromodomain helicase DNA binding protein 7 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CHD8 | Chromodomain helicase DNA binding protein 8 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CHEK2 | Checkpoint kinase 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CHRNB1 | Cholinergic receptor, nicotinic, beta 1 (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CHST11 | Carbohydrate (chondroitin 4) sulfotransferase 11 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Mixed |
CHST3 | Carbohydrate (chondroitin 6) sulfotransferase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
CHSY1 | Chondroitin sulfate synthase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
CHUK | Conserved helix-loop-helix ubiquitous kinase | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
CIITA | Class II, major histocompatibility complex, transactivator | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |